Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Zhongnan Hospital · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
acute-myeloid-leukemia
bortezomib, acute myeloid leukemia, pre-excitation regimen, acute myeloid leukemi, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 825605
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.